We are live on ! Find out more
NVO

Novo Nordisk
NVO

902 hedge funds and large institutions have $15.2B invested in Novo Nordisk in 2022 Q1 according to their latest regulatory filings, with 84 funds opening new positions, 299 increasing their positions, 304 reducing their positions, and 61 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 84 | Existing positions closed: 61

32% more call options, than puts

Call options by funds: $186M | Put options by funds: $141M

2% more funds holding

Funds holding: 886 → 902 (+16)

3% more capital invested

Capital invested by funds: $14.7B → $15.2B (+$496M)

0.69% more ownership

Funds ownership: 14.87% → 15.56% (+0.69%)

0% more funds holding in top 10

Funds holding in top 10: 23 → 23 (0)

2% less repeat investments, than reductions

Existing positions increased: 299 | Existing positions reduced: 304

Holders
902
Holders Change
+16
Holders Change %
+1.81%
% of All Funds
14.23%
Holding in Top 10
23
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.36%
New
84
Increased
299
Reduced
304
Closed
61
Calls
$186M
Puts
$141M
Net Calls
+$45M
Net Calls Change
-$44M

Top Buyers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
+$499M
2
BlackRock
BlackRock
New York
+$161M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$60M
4
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$56.1M
5
VIP
Vantage Investment Partners
Missouri
+$50.2M

Top Sellers

Rank Fund Capital Flow
1
F
Folketrygdfondet
Norway
-$405M
2
ClearBridge Investments
ClearBridge Investments
New York
-$142M
3
Renaissance Technologies
Renaissance Technologies
New York
-$75.2M
4
Capital International Investors
Capital International Investors
California
-$33.6M
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$29.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
FEG
801
Financial Enhancement Group
Indiana
$45K +$2.57K +50 +7%
AF
802
Allworth Financial
California
$44K – – –
MTIC
803
Missouri Trust & Investment Company
Missouri
$44K – – –
SCA
804
Sandy Cove Advisors
Massachusetts
$44K – – –
CWP
805
Concord Wealth Partners
Virginia
$43K -$411 -8 -1%
PGAM
806
Princeton Global Asset Management
New Jersey
$41K – – –
PB
807
Pinnacle Bancorp
Nebraska
$38K -$1.64K -32 -4%
PFBT
808
Parkside Financial Bank & Trust
Missouri
$37K -$4.82K -94 -12%
FAG
809
Fortitude Advisory Group
Washington
$37K – – –
GWSG
810
GPS Wealth Strategies Group
Colorado
$36K – – –
BNP Paribas Financial Markets
811
BNP Paribas Financial Markets
France
$35.5K – – –
CA
812
Clearstead Advisors
Ohio
$35K – – –
JPLA
813
Joseph P. Lucia & Associates
New York
$34K +$31.8K +620 New
NSIM
814
North Star Investment Management
Illinois
$33K – – –
SWM
815
Sugarloaf Wealth Management
Georgia
$33K – – –
VRM
816
Vectors Research Management
New York
$33K – – –
WAM
817
Worth Asset Management
Texas
$32K +$31.8K +620 New
HIA
818
Harbor Investment Advisory
Maryland
$29K – – –
HC
819
Hoese & Co
Minnesota
$28K – – –
WT
820
Washington Trust
Rhode Island
$28K – – –
PWMG
821
Prestige Wealth Management Group
New Jersey
$27K – – –
CGA
822
Channing Global Advisors
Florida
$26K -$188K -3,660 -89%
BWL
823
Bogart Wealth LLC
Virginia
$26K – – –
FMII
824
Farmers & Merchants Investments Inc
Nebraska
$26K +$24K +468 New
AIP
825
Ahrens Investment Partners
Louisiana
$25K – – –
31 32
33
34 35

NVO Hedge Fund Activity: Q1 2022 in Review

902 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q1 2022, worth a combined $15.2B — up 3.4% from $14.7B a quarter earlier.

Buyers outnumbered sellers: 84 funds opened new NVO positions and 61 closed out — a net gain of 23 holders — while 299 added to existing stakes and 304 trimmed.

The largest buyer was Jennison Associates, adding an estimated $499M. The largest seller was Folketrygdfondet, cutting an estimated $405M.

  • 902 institutional investors held Novo Nordisk (NVO) as of Q1 2022, up from 886 in Q4 2021.
  • Funds reported $15.2B of Novo Nordisk stock for Q1 2022, up 3.4% quarter-over-quarter.
  • 84 funds opened new Novo Nordisk positions in Q1 2022 and 61 closed out, a net change of +23 holders.
  • The largest Novo Nordisk buyer in Q1 2022 was Jennison Associates, an estimated $499M added.
  • The largest Novo Nordisk seller in Q1 2022 was Folketrygdfondet, an estimated $405M sold.

Based on aggregated 13F filings for Q1 2022.